Stable Chronic Angina

3

Review clinical trials related to Stable Chronic Angina. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease

This study aim to investigate the association between plasma NT-proBNP levels and the presence, extent and severity of stenosis in patients with suspected coronary artery disease.

Participants needed: 800
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: IRCCS Ospedale San RaffaeleUpdated: Jun 10, 2025Locations: 2Duration: 1 Day
Eligibility criteria

patient referred for elective coronary angiography due to suspected CAD. [+1]

heart failure [+5]

Status: Recruiting

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

The purpose of the COMPLEX Registry is to prospectively and retrospectively collect baseline, clinical and procedural data of patients who have undergone PCI or CABG for complex and/ or calcified chronic CAD, irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. The outcomes will be compared in different clinical subgroups (e.g. PCI vs. CABG). The impact of current PCI techniques/ devices, but also CABG strategies in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.

Participants needed: 5,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Luzerner KantonsspitalUpdated: Oct 29, 2024Locations: 1Duration: 10 Years
Eligibility criteria

Subject >18 years of age [+9]

Patient is <18 years of age [+2]

Status: Recruiting

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

The purpose of the SIROOP Registry is to retrospectively and prospectively collect baseline, clinical and procedural characteristics of patients who have undergone PCI and are treated with either currently available sirolimus or paclitaxel coated DCBs (see Table 1), irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. Outcomes will be compared in different clinical subgroups. The impact of current DCBs in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Luzerner KantonsspitalUpdated: Oct 29, 2024Locations: 1Duration: 10 Years
Eligibility criteria

Subject >18 years of age [+3]

Patient is <18 years of age [+3]